Braille Live

Windows 7 Confirmed For Holiday Season
SEATTLE , Microsoft Corp. said Tuesday that Windows 7, the next version of its computer operating software, will go on sale Oct. 22, in time to possibly give the slumping PC industry a lift in the holiday season.

Windows 7, which will replace the much-complained-about Windows Vista, will be available then on new PCs. Microsoft, the world’s largest software maker, will also sell versions that people can install on existing PCs.
Read the rest of this entry »

Action Needed To Protect Access Rights of Blind To Literature
USA,Canada and the EU attempt to kill treaty to protect blind people’s access to written material USA, Canada and the EU attempt to kill treaty to protect blind people’s access to written material Posted by Cory Doctorow, May 29, 2009 1:52 AM |
permalink Right now, in Geneva, at the UN’s World Intellectual Property Organization, history is being made. For the first time in WIPO history, the body that creates the world’s copyright treaties is attempting to write a copyright treaty dedicated to protecting the interests of copyright users, not just copyright owners. At issue is a treaty to protect the rights of blind people and people with other disabilities that affect reading (people with dyslexia, people who are paralyzed or lack arms or hands for turning pages), introduced by Brazil, Ecuador and Paraguay. This should be a slam dunk: who wouldn’t want a harmonized system of copyright exceptions that ensure that it’s possible for disabled people to get access to the written word?
Read the rest of this entry »

FDA Advisory Panel Recommends Approval of VisionCare’s Implantable Telescope
FDA Advisory Panel Recommends Approval of VisionCare’s Implantable Telescope for End-Stage Macular Degeneration.
Saratoga, CA – March 30, 2009 – VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced the FDA Ophthalmic Devices Advisory Panel unanimously recommended that the FDA approve, with conditions, the premarket application (PMA) for its implantable telescope for End-Stage AMD. The implantable telescope is the first medical device to be recommended by the panel for FDA approval for End-Stage AMD, a leading cause of untreatable blindness in the U.S.
Read the rest of this entry »

Emerging Treatment Stabilizes Vision For People With Dry AMD
Emerging Treatment Stabilizes Vision in People with Dry AMD

Owings Mills, MD – March 26, 2009 – An innovative technology, employing a tiny capsule implanted in the eye, is stabilizing vision in people suffering from dry age-related macular degeneration (AMD). Encapsulated Cell Technology (ECT), developed by Rhode Island-based Neurotech, preserved vision in a majority of the 51 people who participated in a Phase II clinical trial.
Read the rest of this entry »